The vaccine for the RSV virus, which is one of the viruses that causes respiratory tract infections, has been included in the GHS (General Healthcare System). Eligible groups are pregnant women (32–36 weeks), individuals over 75 years old, and individuals aged 60–74 with risk factors (e.g. heart disease, asthma, diabetes, etc.).
If an eligible person wishes to receive the vaccine, they are welcome to get in touch.
